Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Cholangiocarcinoma
Using ctDNA as a Predictive Biomarker in Patients With CCA Before and During Chemotherapy: Subanalysis of the Phase 2 STAMP Trial
Read More
Cholangiocarcinoma
Investigating Alterations in Cancer Driver Genes and Other Mutations in Patients With Intrahepatic CCA: Phase 3 BILCAP Trial
Read More
Cholangiocarcinoma
Using Liquid Biopsy to Detect FGFR2 and Other Actionable Rearrangements in GI Malignancies
Read More
Cholangiocarcinoma
BI 907828, an MDM2-p53 Antagonist, Demonstrated Promising Efficacy in Patients With Advanced BTC
Read More
Cholangiocarcinoma
Patients With Advanced BTC Treated With CTX-009 Plus Paclitaxel in a Phase 2 Study
Read More
Cholangiocarcinoma
The Use of Gunagratinib in Patients With Previously Treated Advanced CCA Harboring FGFR2 Fusions or Rearrangements: A Phase 2 Study
Read More
Cholangiocarcinoma
GemCis and Nab-Paclitaxel Versus GemCis in Advanced BTC: Results From the SWOG 1815 Study
Read More
Cholangiocarcinoma
Risk Factors for Early Relapse in Patients Undergoing Curative Resection in JCOG1202 Subgroup Analysis
Read More
Cholangiocarcinoma
Characteristics of Long-Term Survivors in the TOPAZ-1 Trial
Read More
Cholangiocarcinoma
IMbrave 151: Atezolizumab With or Without Bevacizumab in Combination With GemCis in Advanced BTC
Read More
22
23
24
25
26
27
28
Page 25 of 196
Results 241 - 250 of 1953
